Cases in the Press

Eli Lilly

An Illinois jury said Eli Lilly and Co. must pay $61 million in a whistleblower’s fraud suit alleging that the company made false claims about pricing under Medicaid’s drug rebate program.

Read more
Cases in the Press

Egon Zehnder

Global headhunter Egon Zehnder allegedly cheated the city and the state of New York out of millions under a 10-year tax dodge designed to underreport U.S.-based earnings while ginning up illegitimate losses, according to a recently unsealed tax whistleblower complaint.

Read more
Cases in the Press

ResMed

A major supplier of COVID-19 personal protective equipment to the federal government has settled a $US381 million ($507 million) tax dispute with the Australian Taxation Office.

Read more

August 15, 2024

On August 14-15, 2024, Dr. Brian Becker provided trial testimony to the United States District Court for the District of Delaware concerning fraudulent inducement damages in the medical device industry.

November 9, 2023

On November 9, 2023, Dr. Brian Becker provided trial testimony to the Central District of California concerning class action damages for fund investments.

November 2, 2023

On November 2, 2023, Dr. Brian Becker testified as an expert in economics with specializations in transfer pricing valuation in a dispute involving BlackBerry before the Tax Court of Canada in Toronto.

October 4, 2023

On October 4, 2023, Dr. Brian Becker provided trial testimony concerning damages related to a powerplant in Madagascar in an international arbitration dispute at the International Centre for Dispute Resolution.

September 5, 2023

On September 5, 2023, Dr. Brian Becker provided a trial testimony to the Central District Court of California concerning class action damages for fund investments.

May 30, 2023

On May 30, 2023, Dr. Brian Becker provided a deposition testimony concerning class action damages for fund investments.

November 10, 2022

On November 10, 2022, Dr. Brian Becker provided direct, cross-examination, and “hot tub” testimonies regarding royalty damages in the biopharmaceutical industry at the American Arbitration Association.

Cases in the Press
Cases in the Press

Eli Lilly

An Illinois jury said Eli Lilly and Co. must pay $61 million in a whistleblower’s fraud suit alleging that the company made false claims about pricing under Medicaid’s drug rebate program.

Read more
Cases in the Press

Egon Zehnder

Global headhunter Egon Zehnder allegedly cheated the city and the state of New York out of millions under a 10-year tax dodge designed to underreport U.S.-based earnings while ginning up illegitimate losses, according to a recently unsealed tax whistleblower complaint.

Read more
Cases in the Press

ResMed

A major supplier of COVID-19 personal protective equipment to the federal government has settled a $US381 million ($507 million) tax dispute with the Australian Taxation Office.

Read more
Archives

August 15, 2024

On August 14-15, 2024, Dr. Brian Becker provided trial testimony to the United States District Court for the District of Delaware concerning fraudulent inducement damages in the medical device industry.

November 9, 2023

On November 9, 2023, Dr. Brian Becker provided trial testimony to the Central District of California concerning class action damages for fund investments.

November 2, 2023

On November 2, 2023, Dr. Brian Becker testified as an expert in economics with specializations in transfer pricing valuation in a dispute involving BlackBerry before the Tax Court of Canada in Toronto.

October 4, 2023

On October 4, 2023, Dr. Brian Becker provided trial testimony concerning damages related to a powerplant in Madagascar in an international arbitration dispute at the International Centre for Dispute Resolution.

September 5, 2023

On September 5, 2023, Dr. Brian Becker provided a trial testimony to the Central District Court of California concerning class action damages for fund investments.

May 30, 2023

On May 30, 2023, Dr. Brian Becker provided a deposition testimony concerning class action damages for fund investments.

November 10, 2022

On November 10, 2022, Dr. Brian Becker provided direct, cross-examination, and “hot tub” testimonies regarding royalty damages in the biopharmaceutical industry at the American Arbitration Association.